Competitive inhibition of human organic anion transporters 1 (SLC22A6), 3 (SLC22A8) and 4 (SLC22A11) by major components of the medicinal herb Salvia miltiorrhiza (Danshen)

Drug Metabolism and Pharmacokinetics

Volumn 28, Issue 3, 2013, Pages 220-228

  Wang, Li ^a   Sweet, Douglas H ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

Danshen; Herb drug interaction; Kidney; Organic anion transporter; Renal transport; Solute carrier

Indexed keywords

HERBACEOUS AGENT; LITHOSPERMIC ACID; ORGANIC ANION TRANSPORTER 1; ORGANIC ANION TRANSPORTER 3; ORGANIC ANION TRANSPORTER 4; ROSMARINIC ACID; SALVIANOLIC ACID A; SALVIANOLIC ACID B; TANSHINOL; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; COMPETITIVE INHIBITION; CONTROLLED STUDY; DRUG INTERACTION; DRUG PROTEIN BINDING; DRUG TRANSPORT; EMBRYO; FEMALE; HUMAN; HUMAN CELL; IN VIVO STUDY; KINETICS; NONHUMAN; SALVIA MILTIORRHIZA;

EID: 84876583914     PISSN: 13474367     EISSN: 18800920     Source Type: Journal    
DOI: 10.2133/dmpk.DMPK-12-RG-116     Document Type: Article

References (44)

1. Zhou, L., Zuo, Z. and Chow, M. S.: Danshen: an overview of its chemistry, pharmacology, pharmacokinetics, and clinical use. J. Clin. Pharmacol., 45: 1345-1359 (2005).
2. Cheng, T. O.: Cardiovascular effects of Danshen. Int. J. Cardiol., 121: 9-22 (2007).
3. Jiang, R. W., Lau, K. M., Hon, P. M., Mak, T. C., Woo, K. S. and Fung, K. P.: Chemistry and biological activities of caffeic acid derivatives from Salvia miltiorrhiza. Curr. Med. Chem., 12: 237-246 (2005).
4. Takahashi, K., Ouyang, X., Komatsu, K., Nakamura, N., Hattori, M., Baba, A. and Azuma, J.: Sodium tanshinone IIA sulfonate derived from Danshen (Salvia miltiorrhiza) attenuates hypertrophy induced by angiotensin II in cultured neonatal rat cardiac cells. Biochem. Pharmacol., 64: 745-750 (2002).
5. Tang, M. K., Ren, D. C., Zhang, J. T. and Du, G. H.: Effect of salvianolic acids from Radix Salviae miltiorrhizae on regional cerebral blood flow and platelet aggregation in rats. Phytomedicine, 9: 405-409 (2002).
6. Liu, C. L., Xie, L. X., Li, M., Durairajan, S. S., Goto, S. and Huang, J. D.: Salvianolic acid B inhibits hydrogen peroxide-induced endothelial cell apoptosis through regulating PI3K/Akt signaling. PLoS ONE, 2: e1321 (2007).
7. Zhao, G. R., Zhang, H. M., Ye, T. X., Xiang, Z. J., Yuan, Y. J., Guo, Z. X. and Zhao, L. B.: Characterization of the radical scavenging and antioxidant activities of danshensu and salvianolic acid B. Food Chem. Toxicol., 46: 73-81 (2008).
8. Li, Y. G., Song, L., Liu, M., Hu, Z. B. and Wang, Z. T.: Advancement in analysis of Salviae miltiorrhizae Radix et Rhizoma (Danshen). J. Chromatogr. A, 1216: 1941-1953 (2009).
9. Yuan, D., Pan, Y. N., Fu, W. W., Makino, T. and Kano, Y.: Quantitative analysis of the marker compounds in Salvia miltiorrihiza root and its phytomedicinal preparations. Chem. Pharm. Bull. (Tokyo), 53: 508-514 (2005).
10. Li, X., Yu, C., Cai, Y., Liu, G., Jia, J. and Wang, Y.: Simultaneous determination of six phenolic constituents of danshen in human serum using liquid chromatography/tandem mass spectrometry. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci., 820: 41-47 (2005).
11. Zhang, J. L., Cui, M., He, Y., Yu, H. L. and Guo, D. A.: Chemical fingerprint and metabolic fingerprint analysis of Danshen injection by HPLC-UV and HPLC-MS methods. J. Pharm. Biomed. Anal., 36: 1029-1035 (2005).
12. Lu, T., Yang, J., Gao, X., Chen, P., Du, F., Sun, Y., Wang, F., Xu, F., Shang, H., Wang, Y., Wan, R., Liu, C., Liu, C. and Li, C.: Plasma and urinary tanshinol from Salvia miltiorrhiza (Danshen) can be used as pharmacokinetic markers for cardiotonic pills, a cardiovascular herbal medicine. Drug Metab. Dispos., 36: 1578-1586 (2008).
13. Sweet, D. H., Bush, K. T. and Nigam, S. K.: The organic anion transporter family: from physiology to ontogeny and the clinic. Am. J. Physiol. Renal Physiol., 281: F197-F205 (2001).
14. VanWert, A. L., Gionfriddo, M. R. and Sweet, D. H.: Organic anion transporters: discovery, pharmacology, regulation and roles in pathophysiology. Biopharm. Drug Dispos., 31: 1-71 (2010).
15. Sweet, D. H.: Organic anion transporter (Slc22a) family members as mediators of toxicity. Toxicol. Appl. Pharmacol., 204: 198-215 (2005).
16. Jaehde, U., Sorgel, F., Reiter, A., Sigl, G., Naber, K. G. and Schunack, W.: Effect of probenecid on the distribution and elimination of ciprofloxacin in humans. Clin. Pharmacol. Ther., 58: 532-541 (1995).
17. Burnell, J. M. and Kirby, W. M.: Effectiveness of a new compound, benemid, in elevating serum penicillin concentrations. J. Clin. Invest., 30: 697-700 (1951).
18. VanWert, A. L. and Sweet, D. H.: Impaired clearance of methotrexate in organic anion transporter 3 (Slc22a8) knockout mice: a gender specific impact of reduced folates. Pharm. Res., 25: 453-462 (2008).
19. VanWert, A. L., Bailey, R. M. and Sweet, D. H.: Organic anion transporter 3 (Oat3/Slc22a8) knockout mice exhibit altered clearance and distribution of penicillin G. Am. J. Physiol. Renal Physiol., 293: F1332-F1341 (2007).
20. VanWert, A. L., Srimaroeng, C. and Sweet, D. H.: Organic anion transporter 3 (Oat3/Slc22a8) interacts with carboxyfluoroquinolones, and deletion increases systemic exposure to ciprofloxacin. Mol. Pharmacol., 74: 122-131 (2008).
21. Cutler, M. J., Urquhart, B. L., Velenosi, T. J., Meyer Zu Schwabedissen, H. E., Dresser, G. K., Leake, B. F., Tirona, R. G., Kim, R. B. and Freeman, D. J.: In Vitro and In Vivo Assessment of Renal Drug Transporters in the Disposition of Mesna and Dimesna. J. Clin. Pharmacol., 52: 530-542 (2012).
22. Kyrklund, C., Backman, J. T., Neuvonen, M. and Neuvonen, P. J.: Gemfibrozil increases plasma pravastatin concentrations and reduces pravastatin renal clearance. Clin. Pharmacol. Ther., 73: 538-544 (2003).
23. Nakagomi-Hagihara, R., Nakai, D. and Tokui, T.: Inhibition of human organic anion transporter 3 mediated pravastatin transport by gemfibrozil and the metabolites in humans. Xenobiotica, 37: 416-426 (2007).
24. Yuan, H., Feng, B., Yu, Y., Chupka, J., Zheng, J. Y., Heath, T. G. and Bond, B. R.: Renal organic anion transporter-mediated drug-drug interaction between gemcabene and quinapril. J. Pharmacol. Exp. Ther., 330: 191-197 (2009).
25. Yu, C. M., Chan, J. C. N. and Sanderson, J. E.: Chinese herbs and warfarin potentiation by "Danshen. " J. Intern. Med., 241: 337-339 (1997).
26. Qiu, F., Zhang, R., Sun, J., Jiye, A., Hao, H., Peng, Y., Ai, H. and Wang, G.: Inhibitory effects of seven components of danshen extract on catalytic activity of cytochrome P450 enzyme in human liver microsomes. Drug Metab. Dispos., 36: 1308-1314 (2008).
27. Wang, L. and Sweet, D. H.: Active Hydrophilic Components of the Medicinal Herb Salvia miltiorrhiza (Danshen) Potently Inhibit Organic Anion Transporters 1 (Slc22a6) and 3 (Slc22a8). Evid. Based Complement. Alternat. Med., 2012: Article ID 872458 (2012).
28. Giacomini, K. M., Huang, S. M., Tweedie, D. J., Benet, L. Z., Brouwer, K. L., Chu, X., Dahlin, A., Evers, R., Fischer, V., Hillgren, K. M., Hoffmaster, K. A., Ishikawa, T., Keppler, D., Kim, R. B., Lee, C. A., Niemi, M., Polli, J. W., Sugiyama, Y., Swaan, P. W., Ware, J. A., Wright, S. H., Yee, S. W., Zamek-Gliszczynski, M. J. and Zhang, L.: Membrane transporters in drug development. Nat. Rev. Drug Discov., 9: 215-236 (2010).
29. Wang, L. and Sweet, D. H.: Potential for food-drug interactions by dietary phenolic acids on human organic anion transporters 1 (SLC22A6), 3 (SLC22A8), and 4 (SLC22A11). Biochem. Pharmacol., 84: 1088-1095 (2012).
30. Ho, E. S., Lin, D. C., Mendel, D. B. and Cihlar, T.: Cytotoxicity of antiviral nucleotides adefovir and cidofovir is induced by the expression of human renal organic anion transporter 1. J. Am. Soc. Nephrol., 11: 383-393 (2000).
31. Bent, S.: Herbal medicine in the United States: review of efficacy, safety, and regulation: grand rounds at University of California, San Francisco Medical Center. J. Gen. Intern. Med., 23: 854-859 (2008).
32. Hu, Z., Yang, X., Ho, P. C., Chan, S. Y., Heng, P. W., Chan, E., Duan, W., Koh, H. L. and Zhou, S.: Herb-drug interactions: a literature review. Drugs, 65: 1239-1282 (2005).
33. Fugh-Berman, A.: Herb-drug interactions. Lancet, 355: 134-138 (2000).
34. Whitley, A. C., Sweet, D. H. and Walle, T.: The dietary polyphenol ellagic acid is a potent inhibitor of hOAT1. Drug Metab. Dispos., 33: 1097-1100 (2005).
35. Srimaroeng, C., Chatsudthipong, V., Aslamkhan, A. G. and Pritchard, J. B.: Transport of the natural sweetener stevioside and its aglycone steviol by human organic anion transporter (hOAT1; SLC22A6) and hOAT3 (SLC22A8). J. Pharmacol. Exp. Ther., 313: 621-628 (2005).
36. Wong, C. C., Botting, N. P., Orfila, C., Al-Maharik, N. and Williamson, G.: Flavonoid conjugates interact with organic anion transporters (OATs) and attenuate cytotoxicity of adefovir mediated by organic anion transporter 1 (OAT1/SLC22A6). Biochem. Pharmacol., 81: 942-949 (2011).
37. Wong, C. C., Barron, D., Orfila, C., Dionisi, F., Krajcsi, P. and Williamson, G.: Interaction of hydroxycinnamic acids and their conjugates with organic anion transporters and ATP-binding cassette transporters. Mol. Nutr. Food Res., 55: 979-988 (2011).
38. Bakhiya, N., Arlt, V. M., Bahn, A., Burckhardt, G., Phillips, D. H. and Glatt, H.: Molecular evidence for an involvement of organic anion transporters (OATs) in aristolochic acid nephropathy. Toxicology, 264: 74-79 (2009).
39. Ueo, H., Motohashi, H., Katsura, T. and Inui, K.: Human organic anion transporter hOAT3 is a potent transporter of cephalosporin antibiotics, in comparison with hOAT1. Biochem. Pharmacol., 70: 1104-1113 (2005).
40. Sakurai, Y., Motohashi, H., Ueo, H., Masuda, S., Saito, H., Okuda, M., Mori, M., Matsuura, M., Doi, T., Fukatsu, A., Ogawa, O. and Inui, K.: Expression levels of renal organic anion transporters (OATs) and their correlation with anionic drug excretion in patients with renal diseases. Pharm. Res., 21: 61-67 (2004).
41. Hasegawa, M., Kusuhara, H., Endou, H. and Sugiyama, Y.: Contribution of organic anion transporters to the renal uptake of anionic compounds and nucleoside derivatives in rat. J. Pharmacol. Exp. Ther., 305: 1087-1097 (2003).
42. Yang, X., Wang, Y., Liu, Y. and Tang, X.: Effects of Panax quinquefolium protopanaxadiol saponins on the animal and human plasma protein binding of salvianolic acids in vitro. Asian Journal of Pharmaceutical Sciences, 2: 170-179 (2007).
43. Xu, J. Z., Shen, J., Cheng, Y. Y. and Qu, H. B.: Simultaneous detection of seven phenolic acids in Danshen injection using HPLC with ultraviolet detector. J. Zhejiang Univ. Sci. B, 9: 728-733 (2008).
44. Uwai, Y., Ozeki, Y., Isaka, T., Honjo, H. and Iwamoto, K.: Inhibitory effect of caffeic acid on human organic anion transporters hOAT1 and hOAT3: a novel candidate for food-drug interaction. Drug Metab. Pharmacokinet., 26: 486-493 (2011).